Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Testosterone Replacement Therapy Market Analysis by 2022

Market Research Engine
Posted on: 25 Sep 16
Testosterone Replacement Therapy Market Analysis by 2022

New York, September 26: Market Research Engine has published a new report titled as “Testosterone Replacement Therapy Market by Product Type (Oral Implants, Gums/ Buccal Adhesives, Injections, Patches, Creams/ Gels) - Global Industry Analysis, Trends and Forecast 2016 - 2022”


Browse Full Report:


Testosterone is responsible for the improvement of male sexual characteristics and this hormone formed by the testicles. It is also important to maintain various functions such as sexual function, bone growth, adequate levels of red blood cells, and a sense of well being and muscle bulk. Insufficient production of testosterone causes erectile dysfunction. Erectile dysfunction occurs due to decreased testosterone production to overcome this testosterone replacement therapy is used to improve the problem. Testosterone replacement therapy occurs in various forms containing its own set of advantages and hazards such as subdemal pellets, transdemal patches and injections. Testosterone replacement therapy also helps to recover symptoms of low testosterone. Low testosterone is caused due to age growth it generally lowers down after the mid 30’s and further decreases accordingly to the age factor.

The major driving factors of testosterone replacement therapy market are as follows:

Rise in incidence of testosterone deficiency.
Increase in geriatric populace with high risk of testosterone deficiency.
Increasing awareness about testosterone substitute therapy.

The restraining factors of testosterone replacement therapy market are as follows:

High possibility of side effects associated to testosterone replacement therapy.
Patent expiry of key drugs and entry of generics.

The testosterone replacement therapy market is segmented on the lines of its product type and ingredient type. Based on product type the testosterone replacement therapy market is segmented into oral, implants, gums/ buccal adhesives, injections, patches and creams/ gels. The testosterone replacement therapy market is segmented on the lines of its ingredient type like testosterone, testosterone cypionate, testosterone enanthate, testosterone undecanoate and methyl testosterone. The testosterone replacement therapy marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for testosterone replacement therapy and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for testosterone replacement therapy.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets of Testosterone Replacement Therapy. The reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Testosterone Replacement Therapy Market has been segmented as below:

By Product Type Analysis

Gums/Buccal Adhesives

By Ingredient Type Analysis

Testosterone Cypionate
Testosterone Enanthate
Testosterone Undecanoate
Methyl Testosterone

By Regional Analysis

North America
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all testosterone replacement therapy market globally.

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of testosterone replacement therapy market data.

4) Assess your competitor’s refining portfolio and its evolution.

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 25/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.